Clinical trials in South Korea found that supplements derived from Heukharang (a lactucin-rich lettuce cultivar) and lettuce seed oil produced measurable sleep benefits in adults with mild insomnia; the evidence points to a real, population- and dose-dependent effect rather than a universal cure.
What the Korean trials actually measured and who improved
A randomized, double-blind, placebo-controlled trial in Korean adults aged 30–65 with PSQI scores above 5 tested daily Heukharang lettuce extract for four weeks. Compared with placebo, the extract produced statistically significant improvements in subjective sleep quality and objective gains on polysomnography—including increased total sleep time and better sleep efficiency.
A separate trial of lettuce seed oil targeted older adults with insomnia and reported that roughly 70% of participants noted symptom improvement within one week, versus about 20% on placebo. That rapid onset and the difference in affected age groups are important: the trials focus on mild-to-moderate complaints and older populations, not on severe or complex sleep disorders.
How lactucin acts and what objective recordings show
Lactucin is a sesquiterpene lactone that interacts with GABAA receptor pathways; animal studies show it increases non‑REM sleep and lengthens total sleep time. The mechanism resembles GABAA modulation used by some sedatives, but trial reports emphasize different risk signals—no clear pattern of dependence or tolerance emerged in the short-term studies.
In the Heukharang trial, EEG and full polysomnography corroborated the behavioral reports: decreased wake after sleep onset (WASO) and increases in consolidated non‑REM sleep stages. Those objective endpoints matter because subjective sleep improvements alone can reflect placebo effects or expectation; here both subjective and physiological measures moved in the same direction.
Practical starting point, what to watch, and when to stop
For adults with mild insomnia who want a nonpharmaceutical option, a realistic initial approach is to match the trial regimens: a daily dose consistent with the Heukharang extract trial (the formulation tested was taken daily for four weeks) or a measured serving of lettuce seed oil, and then track outcomes for 1–4 weeks. Use concrete thresholds to judge response: at least a 20–30 minute increase in total sleep time or a clear reduction in wake-after-sleep-onset across several nights are reasonable early signals of benefit.
Stop or reassess if sleep does not improve after two to four weeks, if daytime functioning worsens, or if new symptoms appear (allergic reactions, paradoxical restlessness, or excessive next‑day drowsiness). Because interactions with prescription sedatives and long‑term safety data are not well established, consult a clinician before combining lactucin-containing supplements with other CNS depressants or when treating severe insomnia, pregnancy, or significant comorbidities.
Direct comparisons, decision checkpoints, and remaining unknowns
The two trials differ enough that a quick comparison helps decide whether to try a supplement and how long to test it.
| Feature | Heukharang lettuce extract (Korean RCT) | Lettuce seed oil (older adults trial) |
|---|---|---|
| Population | Adults 30–65 with PSQI > 5 | Older adults with insomnia (geriatric focus) |
| Duration tested | 4 weeks | Reported changes within 1 week (trial length shorter) |
| Objective measures | Polysomnography and EEG (showed more non‑REM, less WASO) | Primarily symptom improvement reports; rapid subjective response noted |
| Placebo comparison | Significant vs placebo on sleep time and efficiency | ~70% improved vs ~20% placebo within one week |
| Safety seen in trials | No significant adverse events reported short‑term | Favorable short‑term profile; long‑term unknown |
| Practical implication | Reasonable for adults with mild insomnia to trial for up to 4 weeks | May be useful for older adults needing rapid relief; check clinician first |
Short Q&A
How long before I should expect a change? In the Heukharang trial measurable sleep gains appeared over four weeks; the lettuce seed oil trial reported many older adults noticing improvement within one week.
Who is a better fit? Best candidates are adults with mild-to-moderate insomnia who prefer nonpharmaceutical options—especially older adults where sedative side effects are a concern; severe insomnia or complex sleep disorders were excluded from these trials.
What are the main safety limits? Short-term safety in trials was acceptable with no major adverse events reported, but long-term safety, optimal dosing, and interactions with other sedatives are not yet established—consult a clinician before combining treatments.